Cargando…
Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
BACKGROUND: COVID-19, a disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), commonly presents as fever, cough, dyspnea, and myalgia or fatigue. Although the majority of patients with COVID-19 have mild symptoms, some are more prone to serious outcomes, including pneum...
Autores principales: | Opoka-Winiarska, Violetta, Grywalska, Ewelina, Roliński, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360379/ https://www.ncbi.nlm.nih.gov/pubmed/32664932 http://dx.doi.org/10.1186/s12916-020-01682-y |
Ejemplares similares
-
PIMS-TS, the New Paediatric Systemic Inflammatory Disease Related to Previous Exposure to SARS-CoV-2 Infection—“Rheumatic Fever” of the 21st Century?
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2021) -
The Impact of Epstein-Barr Virus Infection on Juvenile Idiopathic Arthritis Activity and Patient’s Response to Treatment
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2020) -
Seroprevalence of Antibodies against SARS-CoV-2 in Children with Juvenile Idiopathic Arthritis a Case-Control Study
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2021) -
Programmed Cell Death Protein-1 Upregulation in Response to SARS-CoV-2 in Juvenile Idiopathic Arthritis: A Case-Control Study
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2022) -
Severe COVID-19-Induced Hemophagocytic Lymphohistiocytosis
por: Khan, Shahkar, et al.
Publicado: (2023)